Presentation title: Digital Pathology/Ai As A Strategy To Determine The Pathogenesis Of Multiple Chemical Sensitivity: A Proposal To Demystify A Problematic Puzzle.
Location: USA

BiographyDr. Zev Leifer has a Master’s Degree in Medical Sciences from Harvard University. He has a Ph.D. from New York University in Microbiology.

He was on the faculty of New York Medical College for six years and, for the past 37 years, has been Professor of Microbiology and Pathology at the New York College of Podiatric Medicine.

He taught Pathology Lab, as an all-digital course as the field developed in that direction. He founded The Leifer Institute for Molecular and Digital Pathology, . His research interests involve factors affecting genetic regulation. On the pathology side, he is focused in the training of undergraduate students in the use of the new digital technology.

An MCS patient personally known has triggered a great interest in working towards a treatment for this condition.


We are happy to announce that Dr. Zev Leifer, will Present at the CME/CPD accredited 11th World Digital Pathology & AI UCGCongress Conference, from December 15-17, 2023 in Holiday Inn Dubai, UAE & Virtual.

WhatsApp us:
In-person Register link here:
Register virtually link here:

#digitalpathology #medicaldigitalpathology #Imagingdigipath #digipath #Al #machinelearningAI
#digitalpathologist #pathologyscanners #oncopathology #precisionmedicine
#telepathologypediatricpathology #tissueimaging #integrativepathology #cancerdiagnosis #digitalhistopathology